GSK: latest news, analysis and trading updates | ESM Magazine

Activist Investor Bluebell Takes Stake In GSK

Activist investor Bluebell Capital Partners has taken a stake worth about €10 million in British pharmaceuticals group GlaxoSmithKline in efforts to s...

GSK Names Brian McNamara As CEO Of New Spin-Off

British drugmaker GSK said on Thursday its consumer healthcare head, Brian McNamara, will take over as the chief executive officer of the unit on...

GSK Rejects Elliott's Demands For Board, Consumer Business

GSK's board on Friday rejected Elliott's demands that the British company change its board and sell its consumer healthcare arm after separating it from it...

GSK Unveils Plan For Consumer Healthcare Unit

Britain's GSK has unveiled a detailed plan to spin off its consumer healthcare venture with Pfizer into a separate company by the middle of next...

GSK To Boost Spending Power Of Pharma Business Post Break-up

GlaxoSmithKline will lay out plans to boost the spending power of its research-focused pharmaceuticals business at an investor day on Wednesday, as analyst...

Public And Private Sectors Launch Coalition To Protect Tropical Forests

A new public-private coalition was launched at The Leaders Summit on Climate, aiming to raise more than $1 billion to finance initiatives on prot...

GSK Sees Lower Profit This Year As COVID-19 Disruptions Drag On

GSK warned of a bigger than expected fall in earnings this year as the COVID-19 pandemic continues to disrupt other healthcare treatments and the British d...

GSK Profit Misses Expectations As Vaccine Sales Disappoint, Stockpiling Eases

Britain's GSK fell short of quarterly expectations for profit on Wednesday, as sales of its existing vaccines fell and stockpiling of pain and lung medicat...